comparemela.com

Latest Breaking News On - Mike gesser - Page 1 : comparemela.com

Acorda Therapeutics, Inc (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Operator: Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode.

United statesMike gesserRon cohenTierney saccavinoAcorda therapeutics incChance pharmaceuticalsDisney channelAcorda therapeuticsCall transcript novemberAcorda therapeutics third quarterImport export companies

Acorda Therapeutics, Inc (NASDAQ:ACOR) Q1 2023 Earnings Call Transcript

Operator: Welcome to Acorda Therapeutics First Quarter 2023 Financial and Business Update. [Operator Instructions]. Please be advised that this call is being recorded at the company s request.

United statesTom burnsRon cohenTierney saccavinoMike gesserDonghao chenBob langerMichael gesserJeff randallChance pharmaceuticalsInhalation researchDisney channelHangzhou chance pharmaceuticalsAudit committeeAcorda therapeutics incAcorda therapeutics

Acorda Therapeutics, Inc (NASDAQ:ACOR) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Acorda Therapeutics Fourth Quarter and Year-End 2022 Financial and Business Update. Please be advised that this call is being recorded at the company s request.

United statesBoobalan pachaiyappanMike gesserTierney saccavinoMichael gesserAsieris pharmaRon cohenRam selvarajuAcorda therapeutics incAcorda therapeuticsCall transcript marchAcorda therapeutics fourth quarterLatin americanCoast guardAdjusted opexAlkermes award

Acorda Therapeutics, Inc (ACOR) CEO Ron Cohen on Q2 2022 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (NASDAQ:NASDAQ:ACOR) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Tierney Saccavino - EVP, Corporate Communications Ron Cohen -.

United statesMike gesserTierney saccavinoRon cohenCompany participantsCorporate communicationsAcorda therapeutics incAcorda therapeuticsConference call augustAcorda therapeutic second quarterLatin american

Acorda Therapeutics, Inc (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript

Start Time: 16:30 End Time: 17:02 Acorda Therapeutics, Inc.

United statesMuzamil saleemMike gesserTierney saccavinoRon cohenCompany participantsCorporate communicationsAcorda communications consultantAcorda therapeutics incAcorda grant programStart timeAcorda therapeutics first quarterBiopas laboratoriesLatin america

vimarsana © 2020. All Rights Reserved.